Capital Fund Management (CFM)’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-38,813
Closed -$464K 1718
2021
Q1
$464K Buy
38,813
+9,256
+31% +$105K 0.01% 1149
2020
Q4
$269K Buy
+29,557
New +$229K ﹤0.01% 1221
2020
Q2
Sell
-38,682
Closed -$280K 1702
2020
Q1
$280K Buy
38,682
+7,282
+23% +$54K ﹤0.01% 1259
2019
Q4
$277K Sell
31,400
-100
-0.3% -$748 ﹤0.01% 1632
2019
Q3
$192K Buy
+31,500
New +$177K ﹤0.01% 1584
2019
Q2
Sell
-11,100
Closed -$70K 2007
2019
Q1
$70K Sell
11,100
-700
-6% -$4.9K ﹤0.01% 1620
2018
Q4
$76K Buy
+11,800
New +$90.3K ﹤0.01% 1790
2016
Q4
Sell
-11,100
Closed -$181K 1924
2016
Q3
$181K Buy
11,100
+300
+3% +$4.22K ﹤0.01% 1517
2016
Q2
$103K Buy
+10,800
New +$118K ﹤0.01% 1469

Other funds holding NPTN

Capital Fund Management (CFM)'s NPTN Position: Q2 2021 in Review

Capital Fund Management (CFM) sold out of NEOPHOTONICS CORP (NPTN) in Q2 2021, closing a stake of 38,813 shares — an estimated $464K sold.

Capital Fund Management (CFM) first reported a position in NPTN in Q2 2016 and held it in 9 quarters. The position peaked at $464K in Q1 2021. 138 funds tracked by Wall St. Rank hold NPTN as of Q2 2021.

  • Capital Fund Management (CFM) reported no remaining NEOPHOTONICS CORP position as of Q2 2021 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 38,813 NEOPHOTONICS CORP shares in Q2 2021, an estimated $464K.
  • Capital Fund Management (CFM) first reported a position in NEOPHOTONICS CORP in Q2 2016 and held it in 9 quarters.
  • Capital Fund Management (CFM)'s NEOPHOTONICS CORP position peaked at $464K in Q1 2021.
  • 138 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2021.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2021, filed 12 Aug 2021.